Beta Bionics, Inc. (BBNX) Net Cash Flow (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Net Cash Flow data on file, last reported at -$1.4 million in Q1 2026.

• Quarterly Net Cash Flow fell 111.4% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.2 million (down 160.09% YoY) and the FY2025 annual result came in at $1.1 million, down 70.41% from the prior year.
• Net Cash Flow rose to -$1.4 million in Q1 2026 per BBNX's latest filing, from -$6.9 million in the prior quarter.
• The five-year high for Net Cash Flow was $13.0 million in Q4 2024, with the low at -$9.0 million in Q2 2024.
• Average Net Cash Flow over 3 years is $404444.4, with a median of -$1.4 million recorded in 2026.
• The widest YoY moves for Net Cash Flow: up 367.51% in 2025, down 153.35% in 2025.
• Beta Bionics' Net Cash Flow stood at $13.0 million in 2024, then tumbled by 153.35% to -$6.9 million in 2025, then soared by 80.17% to -$1.4 million in 2026.
• Business Quant data shows BBNX's Net Cash Flow at -$1.4 million in Q1 2026, -$6.9 million in Q4 2025, and $3.4 million in Q3 2025.